Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biodel
Biodel
Biodel's insulin drug found effective in trial
Yahoo/Reuters
Mon, 08/11/14 - 08:01 am
Biodel
insulin
diabetes
BIOD-531
Eight Biotech Stocks Trading Near $5 With Huge Upside Potential
24/7 Wall St
Fri, 02/7/14 - 09:43 am
Array Biopharma
Biodel
Galena Biopharma
Novavax
Protalix BioTherapeutics
Rigel Pharmaceuticals
Synta Pharmaceuticals
Zogenix
Biodel Inc: Strong Biotech 'January Effect' Candidate For 2014
Seeking Alpha
Thu, 01/2/14 - 11:07 am
Biodel
insulin
diabetes
Biodel up 10.5 percent premarket after supply agreement with Becton Dickinson
Reuters
Tue, 12/17/13 - 09:35 am
Biodel
Becton Dickinson
Biodel: Creating A Better, Faster Acting Insulin, The Next Big Thing For Diabetic Therapy
Seeking Alpha
Thu, 09/12/13 - 11:39 am
Biodel
insulin
diabetes
BIOD-123
Biodel's BIOD-123 Achieves Primary Endpoint in Phase 2 Clinical Trial Demonstrating Glycemic Control Comparable to Humalog(R)
Yahoo
Mon, 09/9/13 - 09:52 am
Biodel
BIOD-123
clinical trials
diabetes
type 1 diabetes
Is This a MannKind Killer?
Motley Fool
Tue, 09/3/13 - 09:54 am
MannKind
diabetes
Afrezza
BIOD-123
insulin
Biodel
[video] Biotech's Next Big Thing: Fall Trials
TheStreet.com
Fri, 08/23/13 - 10:20 am
clinical trials
Biodel
Coronado Biosciences
Achillion
BIOD-531
hepatitis C
pig whip worms
Our BioPharma Catalyst Watch List
Seeking Alpha
Thu, 08/15/13 - 12:09 pm
Astex
Biodel
Insmed
MannKind
Onconova
Afrezza
Dacogen
Arikace
Rigosertib
Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
Seeking Alpha
Tue, 08/6/13 - 10:00 am
GLP-1 agonist
diabetes
Oramed
Biodel
Bristol-Myers Squibb
Eli Lilly
MannKind
Novo Nordisk
Merck
Afrezza
Januvia
Victoza
Why Biodel Will Have Positive Phase II Results
Seeking Alpha
Wed, 07/31/13 - 09:20 am
Biodel
BIOD-123
type 1 diabetes
type 2 diabetes
diabetes
BioPharma Catalyst Trade Pick Of The Week: Biodel
Seeking Alpha
Tue, 07/30/13 - 01:58 pm
MannKind
Eli Lilly
Biodel
Astex
3 Biotech Catalysts Primed To Be Successful In Q3
Seeking Alpha
Wed, 07/24/13 - 09:48 am
BIOD-123
Biodel
MannKind
Afrezza
GTx
Unilife: Taking Positions Ahead Of A Key Fiscal Year
Seeking Alpha
Thu, 07/18/13 - 09:32 am
Unilife
Biodel
Biodel: A Biotech Company Weathering The Volatility
Seeking Alpha
Wed, 06/26/13 - 09:44 am
Biodel
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:41 am
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
The Run-Up Trade: Biodel's Insulin Trial Results
TheStreet.com
Thu, 05/30/13 - 09:01 am
insulin
diabetes
Biodel
BIOD-123
MannKind
Afrezza
Biodel: Reemerging From Obscurity In 2013
Seeking Alpha
Thu, 04/11/13 - 11:34 am
Biodel
Eli Lilly
BIOD-123
recombinant human insulin
BIOD-250
Biodel's CEO Discusses F3Q12 Results - Earnings Call Transcript
Seeking Alpha
Fri, 08/10/12 - 06:34 pm
Biodel
earnings
Biodel raises $18.5M in a private placement
The Fly on the Wall
Fri, 06/22/12 - 10:31 am
Biodel
Pages
1
2
3
next ›
last »